Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34320162

High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2021 Dec 9
First author
Hitzler J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Dec 9;138(23):2302-2303. doi: 10.1182/blood.2021013439.
    note
    Source null
    related pmid
    34882214
    relationship
    Comment in
  2. citation
    Blood. 2022 Mar 31;139(13):2085. doi: 10.1182/blood.2022015436.
    note
    Source null
    related pmid
    35357473
    relationship
    Comment in

Authors and identifiers

  1. name
    Hitzler J
    type
    Author
  2. name
    Alonzo T
    type
    Author
  3. name
    Gerbing R
    type
    Author
  4. name
    Beckman A
    type
    Author
  5. name
    Hirsch B
    type
    Author
  6. name
    Raimondi S
    type
    Author
  7. name
    Chisholm K
    type
    Author
  8. name
    Viola S
    type
    Author
  9. name
    Brodersen L
    type
    Author
  10. name
    Loken M
    type
    Author
  11. name
    Tong S
    type
    Author
  12. name
    Druley T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hitzler J
    type
    Author
  2. name
    Alonzo T
    type
    Author
  3. name
    Gerbing R
    type
    Author
  4. name
    Beckman A
    type
    Author
  5. name
    Hirsch B
    type
    Author
  6. name
    Raimondi S
    type
    Author
  7. name
    Chisholm K
    type
    Author
  8. name
    Viola S
    type
    Author
  9. name
    Brodersen L
    type
    Author
  10. name
    Loken M
    type
    Author
  11. name
    Tong S
    type
    Author
  12. name
    Druley T
    type
    Author
bibliography ids
  1. nci-bib-3b1021c3e27c1c5c62a56077
book metadata
content sha256
e1972a191b68502cc248355dd5786fac264711afb0efe3371042c1f2c75b4b99
document type
citation
dois
  1. 10.1182/blood.2021012206
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:34320162
immutable id
pubmed:34320162@e1972a191b68502cc248355dd5786fac264711afb0efe3371042c1f2c75b4b99
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
23
name
Blood
nlm unique id
7603509
pages
2337-2346
volume
138
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Dec 9;138(23):2302-2303. doi: 10.1182/blood.2021013439.
    note
    Source null
    related pmid
    34882214
    relationship
    Comment in
  2. citation
    Blood. 2022 Mar 31;139(13):2085. doi: 10.1182/blood.2022015436.
    note
    Source null
    related pmid
    35357473
    relationship
    Comment in
outcomes validated
false
pmid
34320162
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
d8ca533f28fb22f7a943ae04461d2d1434c1c2bdbd8e8d9259566e4d65c9002a
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Dec 9
precision
day
year
2021
publication types
  1. Clinical Trial
  2. Journal Article
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34320162/
title
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial.

Preserved source evidence · Not medical advice